Comprehensive analysis of a novel mouse model of the 22q11.2 deletion syndrome: a model with the most common 3.0-Mb deletion at the human 22q11.2 locus.
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
05 02 2020
05 02 2020
Historique:
received:
05
06
2019
accepted:
10
01
2020
revised:
03
01
2020
entrez:
19
2
2020
pubmed:
19
2
2020
medline:
22
6
2021
Statut:
epublish
Résumé
The 22q11.2 deletion syndrome (22q11.2DS) is associated with an increased risk for psychiatric disorders. Although most of the 22q11.2DS patients have a 3.0-Mb deletion, existing mouse models only mimic a minor mutation of 22q11.2DS, a 1.5-Mb deletion. The role of the genes existing outside the 1.5-Mb deletion in psychiatric symptoms of 22q11.2DS is unclear. In this study, we generated a mouse model that reproduced the 3.0-Mb deletion of the 22q11.2DS (Del(3.0 Mb)/ +) using the CRISPR/Cas9 system. Ethological and physiological phenotypes of adult male mutants were comprehensively evaluated by visual-evoked potentials, circadian behavioral rhythm, and a series of behavioral tests, such as measurement of locomotor activity, prepulse inhibition, fear-conditioning memory, and visual discrimination learning. As a result, Del(3.0 Mb)/ + mice showed reduction of auditory prepulse inhibition and attenuated cue-dependent fear memory, which is consistent with the phenotypes of existing 22q11.2DS models. In addition, Del(3.0 Mb)/ + mice displayed an impaired early visual processing that is commonly seen in patients with schizophrenia. Meanwhile, unlike the existing models, Del(3.0 Mb)/ + mice exhibited hypoactivity over several behavioral tests, possibly reflecting the fatigability of 22q11.2DS patients. Lastly, Del(3.0 Mb)/ + mice displayed a faster adaptation to experimental jet lag as compared with wild-type mice. Our results support the validity of Del(3.0 Mb)/ + mice as a schizophrenia animal model and suggest that our mouse model is a useful resource to understand pathogenic mechanisms of schizophrenia and other psychiatric disorders associated with 22q11.2DS.
Identifiants
pubmed: 32066675
doi: 10.1038/s41398-020-0723-z
pii: 10.1038/s41398-020-0723-z
pmc: PMC7026107
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
35Subventions
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 18dm0207004h0005
Pays : International
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 18dm0207004h0005
Pays : International
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 18dm0207004h0005
Pays : International
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 17H06096
Pays : International
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 17H06096
Pays : International
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 17H06096
Pays : International
Références
Devriendt, K., Fryns, J. P., Mortier, G., van Thienen, M. N. & Keymolen, K. The annual incidence of DiGeorge/velocardiofacial syndrome. J. Med. Genet. 35, 789–790 (1998).
pubmed: 9733045
pmcid: 1051442
doi: 10.1136/jmg.35.9.789-a
Bassett, A. S. et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am. J. Med. Genet. A. 138, 307–313 (2005).
pubmed: 16208694
pmcid: 3127862
doi: 10.1002/ajmg.a.30984
Gothelf, D. et al. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet. 126, 99–105 (2004).
doi: 10.1002/ajmg.b.20124
Niklasson, L., Rasmussen, P., Oskarsdottir, S. & Gillberg, C. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res. Dev. Disabil. 30, 763–773 (2009).
pubmed: 19070990
doi: 10.1016/j.ridd.2008.10.007
Mok, K. Y. et al. Deletions at 22q11.2 in idiopathic Parkinson’s disease: a combined analysis of genome-wide association data. Lancet Neurol. 15, 585–596 (2016).
pubmed: 27017469
pmcid: 4828586
doi: 10.1016/S1474-4422(16)00071-5
Buckley, E., Siddique, A. & McNeill, A. Hyposmia, symptoms of rapid eye movement sleep behavior disorder, and parkinsonian motor signs suggest prodromal neurodegeneration in 22q11 deletion syndrome. Neuroreport 28, 677–681 (2017).
pubmed: 28574926
doi: 10.1097/WNR.0000000000000815
Kirov, G. et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol. Psychiatry 75, 378–385 (2014).
pubmed: 23992924
doi: 10.1016/j.biopsych.2013.07.022
Grozeva, D. et al. Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophr. Res. 135, 1–7 (2012).
pubmed: 22130109
pmcid: 3315675
doi: 10.1016/j.schres.2011.11.004
Szatkiewicz, J. et al. Copy number variation in schizophrenia in Sweden. Mol. Psychiatry 19, 762–773 (2014).
pubmed: 24776740
pmcid: 4271733
doi: 10.1038/mp.2014.40
The International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455, 237–241 (2008).
pmcid: 3912847
doi: 10.1038/nature07239
Michaelovsky, E. et al. Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Med. Genet. 13, 122 (2012).
pubmed: 23245648
pmcid: 3548696
doi: 10.1186/1471-2350-13-122
Carlson, C. et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am. J. Hum. Genet. 61, 620–629 (1997).
pubmed: 9326327
pmcid: 1715959
doi: 10.1086/515508
Guo, T. W. et al. Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2. Hum. Mol. Genet. 27, 1150–1163 (2008).
doi: 10.1093/hmg/ddy028
Emanuel, B. S. Molecular mechanisms and diagnosis of chromosome 22q11.2 rearrangements. Dev. Disabil. Res. Rev. 14, 11–18 (2008).
pubmed: 18636632
pmcid: 2810965
doi: 10.1002/ddrr.3
Kushima, I. et al. Comparative analyses of copy-number variation in autism spectrum disorder and schizophrenia reveal etiological overlap and biological insights. Cell Rep. 24, 2838–2856 (2018).
pubmed: 30208311
doi: 10.1016/j.celrep.2018.08.022
Lindsay, E. A. et al. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401, 379–383 (1999).
pubmed: 10517636
Merscher, S. et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104, 619–629 (2001).
pubmed: 11239417
doi: 10.1016/S0092-8674(01)00247-1
Stark, K. L. et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760 (2008).
pubmed: 18469815
doi: 10.1038/ng.138
Nilsson, S. R. et al. Assessing the cognitive translational potential of a mouse model of the 22q11.2 microdeletion syndrome. Cereb. Cortex. 26, 3991–4003 (2016).
pubmed: 27507786
pmcid: 5028007
doi: 10.1093/cercor/bhw229
Forsingdal, A. et al. Can animal models of copy number variants that predispose to schizophrenia elucidate underlying biology? Biol. Psychiatry 85, 13–24 (2019).
pubmed: 30144930
doi: 10.1016/j.biopsych.2018.07.004
Boroviak, K., Doe, B., Banerjee, R., Yang, F. & Bradley, A. Chromosome engineering in zygotes with CRISPR/Cas9. Genesis 54, 78–85 (2016).
pubmed: 26742453
pmcid: 4819711
doi: 10.1002/dvg.22915
Hamm, J. P. & Yuste, R. Somatostatin interneurons control a key component of mismatch negativity in mouse visual cortex. Cell Rep. 16, 597–604 (2016).
pubmed: 27396334
pmcid: 4956574
doi: 10.1016/j.celrep.2016.06.037
Triboulet, R., Chang, H. M., Lapierre, R. J. & Gregory, R. I. Post-transcriptional control of DGCR8 expression by the Microprocessor. RNA 15, 1005–1011 (2009).
pubmed: 19383765
pmcid: 2685516
doi: 10.1261/rna.1591709
Goldberg, R., Motzkin, B., Marion, R., Scambler, P. J. & Shprintzen, R. J. Velo-cardio-facial syndrome: a review of 120 patients. Am. J. Med. Genet. 45, 313–319 (1993).
pubmed: 8434617
doi: 10.1002/ajmg.1320450307
Ryan, A. K. et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J. Med. Genet. 34, 798–804 (1997).
pubmed: 9350810
pmcid: 1051084
doi: 10.1136/jmg.34.10.798
Muller, W. et al. The DiGeorge syndrome. 1. clinical evaluation and course of partial and complete forms of the syndrome. Eur. J. Pediatr. 147, 496–502 (1988).
pubmed: 3044796
doi: 10.1007/BF00441974
Markert, M. L. et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J. Pediatr. 132, 15–21 (1998).
pubmed: 9469994
doi: 10.1016/S0022-3476(98)70478-0
Braff, D. L., Swerdlow, N. R. & Geyer, M. A. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am. J. Psychiatry 156, 596–602 (1999).
pubmed: 10200740
Grillon, C., Ameli, R., Charney, D. S., Krystal, J. & Braff, D. Startle gating deficits occur across prepulse intensities in schizophrenic-patients. Biol. Psychiatry 32, 939–943 (1992).
pubmed: 1467378
doi: 10.1016/0006-3223(92)90183-Z
Parwani, A. et al. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol. Psychiatry 47, 662–669 (2000).
pubmed: 10745060
doi: 10.1016/S0006-3223(99)00148-1
Moriwaki, M. et al. Prepulse inhibition of the startle response with chronic schizophrenia: a replication study. Neurosci. Res. 65, 259–262 (2009).
pubmed: 19660506
doi: 10.1016/j.neures.2009.07.009
Campeau, S. & Davis, M. Prepulse inhibition of the acoustic startle reflex using visual and auditory prepulse: disruption by apomorphine. Psychopharmacology 117, 267–274 (1995).
pubmed: 7770602
doi: 10.1007/BF02246101
Young, J. W., Wallace, C. K., Geyer, M. A. & Risbrough, V. B. Age-associated improvements in cross-modal prepulse inhibition in mice. Behav. Neurosci. 124, 133–140 (2010).
pubmed: 20141288
pmcid: 3088993
doi: 10.1037/a0018462
Piskorowski, R. A. et al. Age-dependent specific changes in area CA2 of the hippocampus and social memory deficit in a mouse model of the 22q11.2 deletion syndrome. Neuron 89, 163–176 (2016).
pubmed: 26748091
pmcid: 4706988
doi: 10.1016/j.neuron.2015.11.036
Diamantopoulou, A. et al. Loss-of-function mutation in Mirta22/Emc10 rescues specific schizophrenia-related phenotypes in a mouse model of the 22q11.2 deletion. Proc. Natl Acad. Sci. USA 114, e6127–e6136 (2017).
pubmed: 28696314
pmcid: 5544257
doi: 10.1073/pnas.1615719114
Lascano, A. M., Lalive, P. H., Hardmeier, M., Fuhr, P. & Seeck, M. Clinical evoked potentials in neurology: a review of techniques and indications. J. Neurol. Neurosurg. Psychiatry 88, 688–696 (2017).
pubmed: 28235778
doi: 10.1136/jnnp-2016-314791
Heike, C. L. et al. Sleep disturbances in 22q11.2 deletion syndrome: a case with obstructive and central sleep apnea. Cleft Palate Craniofac. J. 44, 340–346 (2007).
pubmed: 17477750
doi: 10.1597/05-196
Crockett, D. J., Goudy, S. L., Chinnadurai, S. & Wootten, C. T. Obstructive sleep apnea syndrome in children with 22q11.2 deletion syndrome after operative intervention for velopharyngeal insufficiency. Front. Pediatr. 2, 84 (2014).
pubmed: 25157342
pmcid: 4127662
doi: 10.3389/fped.2014.00084
Kennedy, W. P. et al. 22q11.2 Deletion syndrome and obstructive sleep apnea. Int. J. Pediatr. Otorhinolaryngol. 78, 1360–1364 (2014).
pubmed: 24958162
doi: 10.1016/j.ijporl.2014.05.031
Sutton, E. L. Psychiatric disorders and sleep issues. Med. Clin. North Am. 98, 1123–1143 (2014).
pubmed: 25134876
doi: 10.1016/j.mcna.2014.06.009
Charrier, A., Olliac, B., Roubertoux, P. & Tordjman, S. Clock genes and altered sleep-wake rhythms: their role in the development of psychiatric disorders. Int. J. Mol. Sci. 18, e938 (2017).
pubmed: 28468274
doi: 10.3390/ijms18050938
Kon, N. et al. CaMKII is essential for the cellular clock and coupling between morning and evening behavioral rhythms. Genes. Dev. 28, 1101–1110 (2014).
pubmed: 24831701
pmcid: 4035538
doi: 10.1101/gad.237511.114
Lindsay, E. A. et al. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410, 97–101 (2001).
pubmed: 11242049
doi: 10.1038/35065105
Hiroi, N. & Yamauchi, T. Modeling and predicting developmental trajectories of neuropsychiatric dimensions associated with copy number variations. Int. J. Neuropsychopharmacol. 22, 488–500 (2019).
pubmed: 31135887
pmcid: 6672556
doi: 10.1093/ijnp/pyz026
Marissal, T. et al. Restoring wild-type-like CA1 network dynamics and behavior during adulthood in a mouse model of schizophrenia. Nat. Neurosci. 21, 1412–1420 (2018).
pubmed: 30224804
pmcid: 6978142
doi: 10.1038/s41593-018-0225-y
Vergaelen, E., Claes, S., Kempke, S. & Swillen, A. High prevalence of fatigue in adults with a 22q11.2 deletion syndrome. Am. J. Med. Genet. A. 173, 858–867 (2017).
pubmed: 28190295
doi: 10.1002/ajmg.a.38094
Campbell, L. et al. Visual scanning of faces in 22q11.2 deletion syndrome: attention to the mouth or the eyes? Psychiatr. Res. 177, 211–215 (2010).
doi: 10.1016/j.psychres.2009.06.007
Campbell, L. E. et al. Is theory of mind related to social dysfunction and emotional problems in 22q11.2 deletion syndrome (velo-cardio-facial syndrome)? J. Neurodev. Disord. 3, 152–161 (2011).
pubmed: 21544568
pmcid: 3188292
doi: 10.1007/s11689-011-9082-7
Shashi, V. et al. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions. J. Intellect. Disabil. Res. 56, 865–878 (2012).
pubmed: 21883601
doi: 10.1111/j.1365-2788.2011.01477.x
Jalbrzikowski, M. et al. Social cognition in 22q11.2 microdeletion syndrome: relevance to psychosis? Schizophr. Res. 142, 99–107 (2012).
pubmed: 23122739
pmcid: 3714207
doi: 10.1016/j.schres.2012.10.007
Gur, R. E. et al. Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities. Mol. Psychiatry 19, 1205–1211 (2014).
pubmed: 24445907
pmcid: 4450860
doi: 10.1038/mp.2013.189
Badoud, D. et al. Understanding others: a pilot investigation of cognitive and affective facets of social cognition in patients with 22q11.2 deletion syndrome (22q11DS). J. Neurodev. Disord. 9, 35 (2017).
pubmed: 28946869
pmcid: 5613394
doi: 10.1186/s11689-017-9216-7
Reyes, M. R., LeBlanc, E. M. & Bassila, M. K. Hearing loss and otitis media in velo-cardio-facial syndrome. Int. J. Pediatr. Otorhinolaryngol. 47, 227–233 (1999).
pubmed: 10321777
doi: 10.1016/S0165-5876(98)00180-3
Fuchs, J. C. et al. Hearing loss in a mouse model of 22q11.2 deletion syndrome. PLoS ONE 8, e80104 (2013).
pubmed: 24244619
pmcid: 3828191
doi: 10.1371/journal.pone.0080104
Csomor, P. A. et al. On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav. Neurosci. 122, 885–900 (2008).
pubmed: 18729642
doi: 10.1037/0735-7044.122.4.885
Yee, B. K., Chang, T., Pietropaolo, S. & Feldon, J. The expression of prepulse inhibition of the acoustic startle reflex as a function of three pulse stimulus intensities, three prepulse stimulus intensities, and three levels of startle responsiveness in C57BL6/J mice. Behav. Brain Res. 163, 265–276 (2005).
pubmed: 16039728
doi: 10.1016/j.bbr.2005.05.013
Shoji, H. & Miyakawa, T. Relationships between the acoustic startle response and prepulse inhibition in C57BL/6J mice: a large-scale meta-analytic study. Mol. Brain 11, 42 (2008).
doi: 10.1186/s13041-018-0382-7
Vaiceliunaite, A., Erisken, S., Franzen, F., Katzner, S. & Busse, L. Spatial integration in mouse primary visual cortex. J. Neurophysiol. 110, 964–972 (2013).
pubmed: 23719206
pmcid: 3742980
doi: 10.1152/jn.00138.2013
Chun, S. et al. Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models. Science 344, 1178–1182 (2014).
pubmed: 24904170
pmcid: 4349506
doi: 10.1126/science.1253895
Butler, P. D. et al. Dysfunction of early-stage visual processing in schizophrenia. Am. J. Psychiatry 158, 1126–1133 (2001).
pubmed: 11431235
doi: 10.1176/appi.ajp.158.7.1126
Foxe, J. J., Doniger, G. M. & Javitt, D. C. Early visual, processing deficits in schizophrenia: impaired P1 generation revealed by high-density electrical mapping. Neuroreport 12, 3815–3820 (2001).
pubmed: 11726801
doi: 10.1097/00001756-200112040-00043
Doniger, G. M., Foxe, J. J., Murray, M. M., Higgins, B. A. & Javitt, D. C. Impaired visual object recognition and Dorsal/Ventral stream interaction in schizophrenia. Arch. Gen. Psychiatry 59, 1011–1020 (2002).
pubmed: 12418934
doi: 10.1001/archpsyc.59.11.1011
Foxe, J. J., Murray, M. M. & Javitt, D. C. Filling-in in schizophrenia: a high-density electrical mapping and source-analysis investigation of illusory contour processing. Cereb. Cortex 15, 1914–1927 (2005).
pubmed: 15772373
doi: 10.1093/cercor/bhi069
Butler, P. D. et al. Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments. Brain 130, 417–430 (2007).
pubmed: 16984902
doi: 10.1093/brain/awl233
Knebel, J. F., Javitt, D. C. & Murray, M. M. Impaired early visual response modulations to spatial information in chronic schizophrenia. Psychiatry Res. Neuroimaging. 193, 168–176 (2011).
doi: 10.1016/j.pscychresns.2011.02.006
Biria, M. et al. Visual processing deficits in 22q11.2 deletion syndrome. Neuroimage Clin. 17, 976–986 (2018).
pubmed: 29527499
doi: 10.1016/j.nicl.2017.12.028
Yeap, S. et al. Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives. Arch. Gen. Psychiatry 63, 1180–1188 (2006).
pubmed: 17088498
doi: 10.1001/archpsyc.63.11.1180
Schwartz, B. D., Maron, B. A., Evans, W. J. & Winstead, D. K. High velocity transient visual processing deficits diminish ability of patients with schizophrenia to recognize objects. Neuropsychiatry Neuropsychol. Behav. Neurol. 12, 170–177 (1999).
pubmed: 10456801
Schwartz, B. D., Maron, B. A., Evans, W. J. & Winstead, D. K. Smooth pursuit tracking deficits of patients with schizophrenia at specific within-sine wave bins. Neuropsychiatry Neuropsychol. Behav. Neurol. 12, 221–229 (1999).
pubmed: 10527106
Butler, P. D., Harkavy-Friedman, J. M., Amador, X. F. & Goman, J. M. Backward masking in schizophrenia: relationship to medication status, neuropsychological functioning, and dopamine metabolism. Biol. Psychiatry 40, 295–298 (1996).
pubmed: 8871777
doi: 10.1016/0006-3223(96)00007-8
Chen, Y. et al. Dependence of impaired eye tracking on deficient velocity discrimination in schizophrenia. Arch. Gen. Psychiatry 56, 155–161 (1999).
pubmed: 10025440
doi: 10.1001/archpsyc.56.2.155
Chen, Y., Nakayama, K., Levy, D. L., Mathysse, S. & Holzman, P. S. Psychophysical isolation of a motion-processing deficit in schizophrenics and their relatives and its association with impaired smooth pursuit. Pro. Natl Acad. Sci. USA 96, 4724–4729 (1999).
doi: 10.1073/pnas.96.8.4724
Green, M. F. & Nuechterlein, K. H. Backward masking performance as an indicator of vulnerability to schizophrenia. Acta Psychiatr. Scand. 99, 34–40 (1999).
doi: 10.1111/j.1600-0447.1999.tb05981.x
Mehta, N. & Cheng, H. Y. Micro-managing the circadian clock: the role of microRNAs in biological timekeeping. J. Mol. Biol. 425, 3609–3624 (2013).
pubmed: 23142644
doi: 10.1016/j.jmb.2012.10.022
Cheng, H. Y. et al. microRNA modulation of circadian-clock period and entrainment. Neuron 54, 813–829 (2007).
pubmed: 17553428
pmcid: 2590749
doi: 10.1016/j.neuron.2007.05.017